Skip to content
Search

Latest Stories

Release date of Sivakarthikeyan starrer Doctor postponed

Release date of Sivakarthikeyan starrer Doctor postponed

By Murtuza Iqbal

Sivakarthikeyan starrer Doctor was all set to release on 26th March 2021. However, the makers have decided to postpone the release date due to the elections in Tamil Nadu.


Producers KJR Studios tweeted, "#Doctor Your love & support kept us going thus far, requesting you to keep up the support a little bit longer! ❤️? @Siva_Kartikeyan @Nelsondilpkumar @anirudhofficial @SKProdOffl @priyankaamohan."

In the note, they have written, "Doctor has been a wonderful experience from the word go, and your enthusiasm and love for the posters & songs have given us more energy. We were excited about bringing you the film on 26th of March, 2021. Owing to the elections, we will be postponing the release to a later, more suitable date. We're taking this call keeping the best interests of our film, the upcoming elections and most importantly, the fans in mind. We are discussing a better release date with all the core members of the project and will announce it in a few days' time. Until then, we request you to keep up the positivity and support you have showed Doctor from Day 1.We assure you; Doctor will be worth the wait!"

Directed by Nelson Dilipkumar, Doctor also stars Vinay Rai, Priyanka Mohan, and Yogi Babu.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less